$SLGL
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Healthcare
Sector
Biotechnology
Industry
Moshe Arkin
CEO
34
Employees
$90.12
Current Price
$224.26M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 1 | 5 | $217,194.50 | 3,815 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 1 | 12 | $3,187,553.62 | 74,597 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 291 | $63.00 | $18,333.00 | View Details |
| Feb 2, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 100 | $58.00 | $5,800.00 | View Details |
| Jan 27, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 100 | $57.05 | $5,705.00 | View Details |
| Jan 22, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 2,173 | $56.57 | $122,922.48 | View Details |
| Jan 23, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 1,151 | $55.98 | $64,434.02 | View Details |
| Jan 5, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 198 | $42.98 | $8,510.04 | View Details |
| Jan 2, 2026 | Opaleye Management Inc. 10% Owner | Purchase | 2,394 | $41.92 | $100,347.86 | View Details |
| Dec 30, 2025 | Opaleye Management Inc. 10% Owner | Purchase | 35,169 | $41.99 | $1,476,626.74 | View Details |
| Dec 29, 2025 | Opaleye Management Inc. 10% Owner | Purchase | 8,638 | $41.85 | $361,533.99 | View Details |
| Dec 31, 2025 | Opaleye Management Inc. 10% Owner | Purchase | 22,497 | $41.99 | $944,743.52 | View Details |
| Dec 22, 2025 | Opaleye Management Inc. 10% Owner | Purchase | 1,019 | $41.15 | $41,935.62 | View Details |
| Dec 23, 2025 | Opaleye Management Inc. 10% Owner | Purchase | 260 | $41.66 | $10,832.46 | View Details |
| Dec 26, 2025 | Opaleye Management Inc. 10% Owner | Purchase | 1,626 | $41.68 | $67,764.53 | View Details |
9 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated$0.39
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated$0.39
Actual-$1.07
Miss
Revenue
Estimated$6.50M
Actual$696.00K
Miss
EPS
Estimated$0.39
Actual$0.39
Beat
Revenue
Estimated$6.50M
Actual$6.50M
Beat
4 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: